
Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …

Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …

A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …

A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …

Bristol-Myers Squibb has been left somewhat red-faced after its combination of Opdivo (nivolumab) and Yervoy (ipilimumab) failed to show any …

A study emerging from St George’s University of London found that children who slept an hour less than the recommended …

A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …

This month has seen two new additions to Novo Nordisk’s Executive Management team. First of the pair is Camila Sylvest, …

Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …

Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of …

A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits …

Simon Williams, Head of Communications and Policy at Heart UK, discusses the threat posed by cholesterol in the development of …

NICE has dished out a double judgement turning down two drugs for advanced renal cell carcinoma, a form of kidney …

The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …

The FDA has launched an investigation after five deaths thought to be caused by an obesity treatment surgery in which …